Difference between revisions of "Exit through the App Store?A rapid evidence review on the technical considerations and societal implications of using technology to transition from the COVID-19 crisis (Q4511)"
Jump to navigation
Jump to search
(Created a new Item: #quickstatements; #temporary_batch_1587471774296) |
(Created claim: concerns (P110): immunity passport (Q4512)) |
||||||||||||||
(5 intermediate revisions by the same user not shown) | |||||||||||||||
Property / instance of | |||||||||||||||
+ | |||||||||||||||
Property / instance of: report / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / date | |||||||||||||||
+ | 20 April 2020
| ||||||||||||||
Property / date: 20 April 2020 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / concerns | |||||||||||||||
+ | |||||||||||||||
Property / concerns: Coronadata / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / concerns | |||||||||||||||
+ | |||||||||||||||
Property / concerns: Contact tracing / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / concerns | |||||||||||||||
+ | |||||||||||||||
Property / concerns: immunity passport / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / quote | |||||||||||||||
+ | The review focuses on three technologies in particular: digital contact tracing, symptom tracking apps and immunity certification. | ||||||||||||||
Property / quote: The review focuses on three technologies in particular: digital contact tracing, symptom tracking apps and immunity certification. / rank | |||||||||||||||
+ | Normal rank |
Latest revision as of 21:46, 23 April 2020
report published by Ada Lovelace Institute on April 20,2020
Language | Label | Description | Also known as |
---|---|---|---|
English |
Exit through the App Store?A rapid evidence review on the technical considerations and societal implications of using technology to transition from the COVID-19 crisis
|
report published by Ada Lovelace Institute on April 20,2020
|
Statements
20 April 2020
0 references
The review focuses on three technologies in particular: digital contact tracing, symptom tracking apps and immunity certification.
0 references